SEMA4C and breast carcinoma: For instance, semaphorin 4C (SEMA4C) has shown promising diagnostic potential for breast cancer, with elevated serum levels significantly associated with tumor presence and reduced levels postsurgery, suggesting its utility in monitoring disease progression [33].